Solve Therapeutics
PrivateLast Round
VC Round
Nov 17, 2025
Total Funding Raised
$126M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Solve Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a VC Round in November 2025.
Solve Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) and a novel diagnostic platform for solid tumor malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solve Therapeutics Comparables
Compare Solve Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcentrx Therapeutics | 88% | |
| Ona Therapeutics | 83% | |
| Duality Biotherapeutics Inc | 77% |
For institutional investors. Book with your work email.
Solve Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 17, 2025 | ||||
| VC Round | Dec 26, 2024 | ||||
| Series A | Dec 14, 2022 |
For institutional investors. Book with your work email.
Solve Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | VC Round, Series A |
| SymBiosis Capital Management | VC Round |
| Balyasny Asset Management L.P. | VC Round |
| B Capital Group | VC Round |
| Ally Bridge Group | VC Round |
| DC Ventures | VC Round |
| Abingworth | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
$120M raised in early funding.
- Dec 26, 2024
$75M raised with participation from General Atlantic and Citadel.
For institutional investors. Book with your work email.
Solve Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Solve Therapeutics's valuation, stock price, and market status.
Is Solve Therapeutics a public or private company?
Solve Therapeutics is a private company.
What is the current stock price of Solve Therapeutics?
Solve Therapeutics is a private company, so its shares have no public market price. Caplight tracks Solve Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Solve Therapeutics worth (valuation)?
Valuation information for Solve Therapeutics is not publicly available.
Can I buy Solve Therapeutics stock?
Solve Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Solve Therapeutics's last funding round?
Solve Therapeutics's most recent funding round was VC Round on November 17, 2025.
Who are the main investors in Solve Therapeutics?
Key investors in Solve Therapeutics include Yosemite.
Will Solve Therapeutics IPO soon?
No public IPO plans have been announced for Solve Therapeutics.
How can I track Solve Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Solve Therapeutics's shares on secondary markets.